Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients

Eur J Clin Microbiol Infect Dis. 1998 May;17(5):365-7. doi: 10.1007/BF01709465.

Authors

G Angarano¹, P Maggi, S L Coppola, R L Cavaliere

Affiliation

¹ Department of Infectious Diseases, University of Bari-Policlinico, Italy.

PMID: 9721971
DOI: 10.1007/BF01709465

No abstract available

MeSH terms

AIDS-Related Opportunistic Infections / drug therapy*
Adult
Antiprotozoal Agents / therapeutic use*
Bone Marrow / parasitology
Female
Humans
Itraconazole / therapeutic use*
Leishmaniasis, Visceral / drug therapy*
Male
Secondary Prevention

Substances

Antiprotozoal Agents
Itraconazole